O25 Efficacy of anifrolumab in active systemic lupus erythematosus (SLE): patient subgroup analysis of BICLA response in 2 phase 3 trials

2020 ◽  
Author(s):  
Eric F Morand ◽  
Richard Furie ◽  
Yoshiya Tanaka ◽  
Rubana N Kalyani ◽  
Gabriel Abreu ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Lupus Erythematosus ◽  
Subgroup Analysis ◽  
Active Systemic Lupus Erythematosus ◽  
Systemic Lupus ◽  
Phase 3 ◽  
Patient Subgroup

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

The Lancet ◽  
2011 ◽  
Vol 377 (9767) ◽  
pp. 721-731 ◽  
Author(s):  
Sandra V Navarra ◽  
Renato M Guzmán ◽  
Alberto E Gallacher ◽  
Stephen Hall ◽  
Roger A Levy ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Lupus Erythematosus ◽  
Active Systemic Lupus Erythematosus ◽  
Efficacy And Safety ◽  
Systemic Lupus ◽  
Phase 3
Sign in / Sign up

Export Citation Format

Share Document